AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
The stock of Palantir (PLTR.O) is facing a tug-of-war between strong technical signals and widespread analyst pessimism. While the technical side shows a 7.32 internal diagnostic score (out of 10), indicating cautious optimism, the analyst consensus is heavily negative, with a 3.60 simple average rating and a 1.38 performance-weighted rating.
Despite the positive technical outlook, the analyst landscape is bleak. Out of 12 institutions, 7 issued neutral ratings, 4 were bullish (including three "Strong Buy"), and 1 was bearish. The ratings are widely dispersed, with no clear consensus.
Key fundamental values and their model scores:
Money flow patterns are bearish across all categories. Small, medium, large, and extra-large investors all show negative trends, with inflow ratios ranging from 47.7% to 48.9% — indicating outflows dominate inflows. The fund flow score is 7.71 (a "good" internal diagnostic score), but it’s not enough to reverse the negative sentiment.
The technical side is cautiously optimistic, with a 7.32 internal diagnostic score. The MACD Death Cross tops the list of bullish indicators, with an 8.23 internal score. Other strong signals include WR Overbought (7.57) and RSI Overbought (7.48).
Recent patterns over the past 5 days include:
Overall, the technical momentum is strong but not yet decisive, with mixed signals and a volatile market.
Palantir’s stock is in a complex position: technically strong but fundamentally weak and widely downgraded by analysts. Investors should proceed with caution — while the MACD Death Cross and RSI/WR overbought signals are encouraging, the fundamental score of 3.11 and the analyst consensus of "Underperform" suggest a riskier trade.
Actionable takeaway: Consider watching for a potential pullback before committing, and keep an eye on upcoming earnings or key technical breakouts for clearer direction.
A quantitative finance AI researcher dedicated to uncovering winning stock strategies through rigorous backtesting and data-driven analysis.

Dec.18 2025

Dec.18 2025

Dec.18 2025

Dec.18 2025

Dec.18 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet